OKYO Pharma Ltd ADR (OKYO) — Strategic Asset Allocation Index
OKYO Pharma Ltd ADR (OKYO) has a Strategic Asset Allocation Index of 0.1% as of March 2022. Strategic assets (PP&E of $3.98K plus long-term investments of $-) total $3.98K, measured against net assets of $2.95 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See OKYO net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
OKYO Pharma Ltd ADR Strategic Asset Allocation Index (2019–2022)
This chart shows how OKYO Pharma Ltd ADR's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2022. As of March 2022, the index stands at 0.1%, representing strategic assets of $3.98K against net assets of $2.95 Million USD. For live market cap and overall valuation, see OKYO company net worth.
Annual Strategic Asset Allocation Index for OKYO Pharma Ltd ADR (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for OKYO Pharma Ltd ADR from 2019 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See OKYO net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $3.98K | $3.98K | $- | $2.95 Million | ▼ -1.3 pp |
| 2021 | 1.4% | $75.81K | $75.81K | $- | $5.32 Million | ▲ +1.2 pp |
| 2019 | 0.3% | $847.00 | $847.00 | $- | $333.14K | — |